Impact of New Technologies on the Natural History of Benign Prostatic Hyperplasia

  • J. Fitzpatrick


A number of recent technological advances have been made in the treatment of benign prostatic hyperplasia (BPH), creating considerable expectation of improved management of the condition. Since these advances predominantly involve interventional therapy, they require critical evaluation of their efficacy and effectiveness. Unfortunately, the shortcomings of some of these therapies are often hidden by the relatively uncritical analysis of open, short-term studies. From both the medical practitioner’s and the patient’s perspectives it is clear that any new interventional therapies must be seen to have some definite benefit over the use of transurethral resection of the prostate (TURP) in the management of BPH.


Benign Prostatic Hyperplasia Balloon Dilatation Benign Prostatic Hypertrophy Interventional Therapy Peak Flow Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abbou CC, Colombel M, Payan C, Beurton D, Viens-Bitker C, Richard F, Boccon-Gibod L, Leduc A, Jardin A, Chatelain C, Thibault P, Hozneka A (1994) The efficiency of microwave induced hyperthermia in the treatment of BPH: the Paris public hospitals’ experience. In: Kurth KH, Newling DWW (eds) Benign prostatic hyperplasia, recent progress in clinical research and practice. Wiley-Liss, New York, pp 449–453Google Scholar
  2. Burhenne HJ, Chisholm RJ, Quenville F (1994) Prostatic hyperplasia: radiological intervention. Radiology 152:655–657Google Scholar
  3. Dahlstrand C, Giersson G, Fall M, Pettersson S (1993) Transurethral microwave thermotherapy versus transurethral resection for benign prostatic hyperplasia: preliminary results of a randomised study. Eur Urol 23:292–298PubMedGoogle Scholar
  4. Donatucci CF, Berger N, Kreder KJ, Donohue RE, Raife MJ, Crawford ED (1993) Randomised clinical trial comparing balloon dilatation to transurethral resection of prostate for benign prostatic hyperplasia. Urology 42:42–49PubMedCrossRefGoogle Scholar
  5. Dowd JB, Smith JJ (1990) Balloon dilatation of the prostate. Urol Clin North Am 17:671–677PubMedGoogle Scholar
  6. Flam TA, Roth RA, Babayan RK, Ebre B (1992) Laser in the management of benign prostatic hypertrophy. In: Fitzpatrick JM (ed) Non-surgical treatment of BPH. Churchill-Livingstone, Edinburgh, pp 253–266Google Scholar
  7. Foster RS, Bihrle R, Sanghvi NT, Fry FJ, Donohue JP (1993) High-intensity focused ultrasound in the treatment of prostatic disease. Eur Urol 23[Suppl l]:29–33PubMedGoogle Scholar
  8. Gill KP, Machan LS, Allison DJ, Williams G (1989) Bladder outflow tract obstruction and urinary retention for benign prostatic hypertrophy treated by balloon dilatation. Br J Urol 64:618–622PubMedCrossRefGoogle Scholar
  9. Gonder MJ, Soanes WA, Smith V (1964) Experimental prostatic cryosurgery. Invest Urol 1:610–619PubMedGoogle Scholar
  10. Green NA (1989) Cryosurgery. In: Fitzpatrick JM, Krane RJ (eds) The prostate. Churchill-Livingstone, Edinburgh, pp 229–236Google Scholar
  11. Kaplan SA, Merill DC, Mosely WG, Benson RC Jr, Chiou RK, Fuselier HA, Parra RO (1993) Titanium intraprostatic stent: United States experience. J Urol 150:1624–1629PubMedGoogle Scholar
  12. Kirby RS, Heard SR, Holmes S, Vale J, Bryan J (1992) The ASI titanium stent in the management of bladder outflow obstruction due to benign prostatic hyperplasia. In: Fitzpatrick JM (ed) Non-surgical treatment of BPH. Churchill-Livingstone, Edinburgh, pp 165–172Google Scholar
  13. Klein LA, Lemming D (1989) Balloon dilatation for prostatic obstruction. Urology 32:198–201CrossRefGoogle Scholar
  14. Laduc R, Bloem FAG, Debruyne FMJ (1992) Transurethral microwave therapy (TUMT) in the treatment of patients with benign prostatic hyperplasia. Eur Urol Update Ser 1:42–47Google Scholar
  15. Lepor H, Sypherd D, Machi G, Denis J (1992) Randomised double-blind study comparing the effectiveness of balloon dilatation of the prostate and cystoscopy for the treatment of symptomatic benign prostatic hyperplasia. J Urol 147:639–644PubMedGoogle Scholar
  16. Madersbacher S, Kratzik C, Szabo N, Susani M, Vingers L, Marberger M (1993) Tissue ablation in benign prostatic hyperplasia with high-intensity focused ultrasound. Eur Urol 23[Suppl l]:39–43PubMedGoogle Scholar
  17. McCullough DL, Roth RA, Babayan RK, Gordon JO, Reese JH, Crawford ED, Fuselier HA, Smith JA, Murchison JR, Kaye KW (1993) Transurethral ultrasound-guided laser-induced prostatectomy: national human co-operative study results. J Urol 15:1607–1611Google Scholar
  18. McLoughlin J, Keane PF, Jaeger R, Machan LS, Williams G (1991) Dilatation of the prostatic urethra with a 35 mm balloon. Br J Urol 67:177–181PubMedCrossRefGoogle Scholar
  19. Milroy E (1992) A new treatment for prostate obstruction; the permanently implanted urolume wallstent. In: Fitzpatrick JM (ed) Non-surgical treatment of BPH. Churchill-Livingstone, Edinburgh, pp 119–127Google Scholar
  20. Mulvin D, Creagh T, Kelly D, Smith J, Quinlan D, Fitzpatrick J (1994) Transurethral microwave thermotherapy versus transurethral catheter therapy for benign prostatic hyperplasia. Eur Urol 26:6–9PubMedGoogle Scholar
  21. Nordling J, Holm HH, Klarskov P, Nielsen KK, Andersen JT (1989) The intraprostatic spiral: a new device for insertion with the patient under local anaesthesia and with ultrasonic guidance with 3 months follow-up. J Urol 142:756–758PubMedGoogle Scholar
  22. Norris JP, Norris DM, Lee RD, Rubenstein MA (1993) Visual laser ablation of prostate: clinical experience in 108 patients. J Urol 150:1612–1614PubMedGoogle Scholar
  23. Ogden CW, Reddy P, Johnson H, Ramsay JWA, Carter S (1993) Sham versus transurethral microwave therapy in patients with symptoms of benign prostatic bladder outflow obstruction. Lancet 341:14–17PubMedCrossRefGoogle Scholar
  24. Poulsen AL, Schou J, Evesen H, Nordling J (1993) Memokath: a second generation of intraprostatic spirals. Br J Urol 72:331–334PubMedGoogle Scholar
  25. Roth RA, Aretz HT (1991) Transurethral ultrasound-guided laser induced prostatectomy (TULIP procedure): a canine prostate feasibility study. J Urol 146:1128–1135PubMedGoogle Scholar
  26. Schulman CC, Zlotta AR, Rasor JS, Hourriez L, Noel JC, Edwards SD (1993) Transurethral needle ablation (TUNA): safety, feasibility and tolerance of a new office procedure for treatment of benign prostatic hyperplasia. Eur Urol 24:415–423PubMedGoogle Scholar
  27. Vallancien G, Chartier-Kastler E, Bataille N, Chopin D, Harouni M, Bougaran J (1993) Focused extracorporeal pyrotherapy. Eur Urol 23[Suppl 1]:48–52PubMedGoogle Scholar
  28. Williams G, Coulange C, Milroy E, Sarramon JP, Rubben H (1993) The Urolume, a permanently implanted prostatic stent for patients at high risk for surgery. Br J Urol 72:335–340PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • J. Fitzpatrick

There are no affiliations available

Personalised recommendations